Literature DB >> 8406673

Monoamine oxidase-B in astrocytes.

J Ekblom1, S S Jossan, M Bergström, L Oreland, E Walum, S M Aquilonius.   

Abstract

In the present report we describe the astrocytic localization and content of monoamine oxidase-B (MAO-B) by means of a 3H-L-deprenyl emulsion autoradiography in primary cultures of rat astrocytes, in cryosectioned astrocytoma surgical specimen, and in cryosections of human spinal cords from patients dying in amyotrophic lateral sclerosis (ALS) and controls. The occurrence of MAO-B enzyme protein depends on the degree of cellular differentiation as demonstrated by studies on astrocytes in primary cultures analyzed at two different stages of maturation. Highly differentiated cells exhibited high relative enzyme concentration whereas glioblasts lacked or showed very low contents of MAO-B enzyme. This was further substantiated by studies performed on human astrocytoma tissue using 3H-L-deprenyl emulsion autoradiography in combination with immunohistochemical detection of glial fibrillary acidic protein (GFAP). Regional increases of MAO-B concentration were found in ALS lumbar sections with quantitative 3H-L-deprenyl autoradiography. On the basis of results obtained from double staining for GFAP and MAO-B, the increase in MAO-B seemed to be due to an increased number of astrocytes as well as an increased content of MAO-B in reactive species of astrocytes. A cell culture model has been used that produces cells with morphology and GFAP-content similar to reactive cells. These astrocytes exhibited high relative content of the MAO-B enzyme protein. In the light of the presented data, taking into account the finding that a subpopulation of reactive cells contained low levels of MAO-B, a heterogeneity among reactive astrocytes was observed.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8406673     DOI: 10.1002/glia.440080208

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  32 in total

1.  Imaging of neuroinflammation.

Authors:  Andrea Ciarmiello
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-12       Impact factor: 9.236

Review 2.  Translational potential of astrocytes in brain disorders.

Authors:  Alexei Verkhratsky; Luca Steardo; Vladimir Parpura; Vedrana Montana
Journal:  Prog Neurobiol       Date:  2015-09-16       Impact factor: 11.685

3.  Increased L-DOPA-derived dopamine following selective MAO-A or -B inhibition in rat striatum depleted of dopaminergic and serotonergic innervation.

Authors:  O Sader-Mazbar; Y Loboda; M J Rabey; J P M Finberg
Journal:  Br J Pharmacol       Date:  2013-11       Impact factor: 8.739

Review 4.  Inhibitors of MAO-B and COMT: their effects on brain dopamine levels and uses in Parkinson's disease.

Authors:  John P M Finberg
Journal:  J Neural Transm (Vienna)       Date:  2018-11-01       Impact factor: 3.575

5.  Monoamine Oxidase B Total Distribution Volume in the Prefrontal Cortex of Major Depressive Disorder: An [11C]SL25.1188 Positron Emission Tomography Study.

Authors:  Sho Moriguchi; Alan A Wilson; Laura Miler; Pablo M Rusjan; Neil Vasdev; Stephen J Kish; Grazyna Rajkowska; Junming Wang; Michael Bagby; Romina Mizrahi; Ben Varughese; Sylvain Houle; Jeffrey H Meyer
Journal:  JAMA Psychiatry       Date:  2019-06-01       Impact factor: 21.596

6.  Effects of depression, cigarette smoking, and age on monoamine oxidase B in amygdaloid nuclei.

Authors:  Beata Karolewicz; Violetta Klimek; He Zhu; Katalin Szebeni; Emily Nail; Craig A Stockmeier; Laurel Johnson; Gregory A Ordway
Journal:  Brain Res       Date:  2005-05-10       Impact factor: 3.252

7.  In vivo imaging of astrocytosis in Alzheimer's disease: an ¹¹C-L-deuteriodeprenyl and PIB PET study.

Authors:  Alexander Frizell Santillo; Juan Pablo Gambini; Lars Lannfelt; Bengt Långström; Luohija Ulla-Marja; Lena Kilander; Henry Engler
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-08-19       Impact factor: 9.236

8.  Corticosterone-sensitive monoamine transport in the rat dorsomedial hypothalamus: potential role for organic cation transporter 3 in stress-induced modulation of monoaminergic neurotransmission.

Authors:  Paul J Gasser; Christopher A Lowry; Miles Orchinik
Journal:  J Neurosci       Date:  2006-08-23       Impact factor: 6.167

Review 9.  Inflaming the brain: CRPS a model disease to understand neuroimmune interactions in chronic pain.

Authors:  C Linnman; L Becerra; D Borsook
Journal:  J Neuroimmune Pharmacol       Date:  2012-11-29       Impact factor: 4.147

Review 10.  Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond.

Authors:  Hristelina Ilieva; Magdalini Polymenidou; Don W Cleveland
Journal:  J Cell Biol       Date:  2009-12-14       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.